Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
Comprehensive slideset updated regularly to include the latest data and guidance on COVID prevention and treatment in special populations and patients with certain comorbidities.
Comprehensive slideset updated regularly to include the latest data and guidance on COVID-19 symptoms and clinical manifestations.
Comprehensive slideset updated regularly to include the latest data and guidance on treatments for COVID-19, including authorized and investigational agents.
Comprehensive slideset updated regularly to include the latest data and guidance on COVID-19 variants and vaccinations for COVID-19, including authorized and investigational agents.
In this module, expert faculty answer healthcare professionals’ questions about COVID-19 prevention, screening, diagnosis, disease management, and treatment. New questions will be added and responses will be further developed as more data emerge.
Hear expert insights on why extra doses and boosters of the SARS-CoV-2 vaccines are recommended for certain populations, and learn recommendations regarding mixing and matching booster doses.
Hear expert insights on the rationale for the use of monoclonal antibodies for postexposure prophylaxis in high-risk populations.
Hear expert insights on the use of IV and oral antiviral agents for the treatment of nonhospitalized patients with COVID-19.
Hear expert insights on a stepwise approach to evaluate treatment candidacy for oral antiviral agents for COVID-19 and practical considerations for their use.
Hear expert insights on how the omicron variant is affecting monoclonal antibody treatments for COVID-19.
Get expert insights on the symptoms, causes, risk factors, timeline, and treatment considerations for long COVID, or postacute sequelae of COVID-19 infection.
The ever-evolving COVID-19 vaccination landscape has created many questions about who should receive additional vaccine doses, when, and why. Hear expert faculty discuss COVID-19 vaccination efficacy, the rationale for third doses and booster doses, and the data behind mixing and matching of booster doses.
Oral antiviral agents offer a new treatment option for nonhospitalized adult patients with COVID-19. Hear expert faculty discuss the safety and efficacy data of molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir in outpatient adults with mild to moderate COVID-19.
Do COVID-19 treatments retain their efficacy against the SARS-CoV-2 omicron variant? Hear expert faculty discuss the use of direct-acting, small-molecule antiviral agents and monoclonal antibodies during the omicron era.
Transmissibility, disease severity, and vaccine effectiveness are different with the SARS-CoV-2 omicron variant compared with the ancestral virus and prior variants. Hear expert faculty discuss what we know about omicron.
Long COVID is a syndrome that can occur in some patients following their COVID-19 infection. Hear expert faculty discuss what is known to date about long COVID, including potential causes, risk factors, signs and symptoms, and treatment strategies under consideration.